State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection-Reference-Cited by-同舟云学术

State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection

Published:2021-12-20 Issue:2 Volume:42 Page:288-298
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Schemmer Peter¹^ORCID,Burra Patrizia²^ORCID,Hu Rey‐Heng³,Hüber Christian M.⁴,Loinaz Carmelo⁵,Machida Keigo⁶,Vogel Arndt⁷,Samuel Didier⁸^ORCID

Affiliation:

1. General, Visceral and Transplant Surgery Department of Surgery Medical University of Graz Graz Austria

2. Department of Surgery, Oncology, and Gastroenterology Padua University Hospital Padua Italy

3. Department of Surgery National Taiwan University Hospital Taipei Taiwan

4. Biotest AG Dreieich Germany

5. Department of General and Digestive Surgery University Hospital 12 de Octubre Madrid Spain

6. Keck Hospital of University of Southern California Los Angeles California USA

7. Department of Gastroenterology, Hepatology and Endocrinology Medizinische Hochschule Hannover Hannover Germany

8. Centre Hepatobiliaire University Hospital Paul Brousse University Paris‐Saclay and Inserm‐Paris Saclay Research Unit 1193 Villejuif France

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15124

Reference82 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

3. Management of hepatitis B virus infection;EASL Clinical Practice Guidelines;J Hepatol,2017

4. Hepatitis B cure: From discovery to regulatory approval

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment;Advanced Therapeutics;2024-07-06

2. Advanced lung cancer inflammation index predicts overall survival of hepatocellular carcinoma after hepatectomy;Frontiers in Oncology;2024-02-08

3. HBV and HCV Infection Prophylaxis in Liver Transplant Recipients;Infectious Diseases;2023-12-20

4. Clinical Results, Risk Factors, and Future Directions of Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-05

5. Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment;Viruses;2022-10-26